BD completes Carmel Pharma buy; Neoprobe names Troup as chairman;

> Becton, Dickinson has completed its acquisition of Carmel Pharma, a Swedish company that manufactures the PhaSeal system, a closed-system drug transfer device for the safe handling of hazardous drugs that are packaged in vials. BD release

> Neoprobe has tapped Gordon Troup as its chairman of the board. He succeeds Carl Aschinger, Jr. Neoprobe release

> Bain Capital and Avista Capital Partners are reportedly looking to raise financing for a takeover offer for Kinetic Concepts that would top Apax Partners' $5 billion bid, according to sources familiar with the plan. News

> OrbusNeich's Genous Stent showed no significant difference in the rate of target vessel failure at two years compared with the Taxus Liberte paclitaxel-eluting stent in patients with de novo coronary artery lesions carrying a high risk for restenosis. OrbusNeich release

> Dan Mans has joined Osprey Medical as its VP of clinical and regulatory affairs. Osprey release

> Oxford Finance has announced that it closed a $20 million senior secured term loan with Keystone Dental. Proceeds of the loan were used to pay off an existing line of credit and fund growth and working capital. Oxford release

And Finally... Eric Peper, a co-founder of St. Louis' Pepex Biomedical, has been indicted by a federal grand jury on charges related to healthcare fraud, money laundering and dispensing controlled substances that led to four deaths. Pepex has said it only recently became aware of allegations against Peper, who has not been with the company for years. Pepex specializes in developing, manufacturing and marketing disposable miniaturized electrochemical biosensors, according to its website. Item